title: Multiple sclerosis and pregnancy prescriptions.
abstract: Multiple sclerosis (MS) is a major neurologic disorder which preferentially affects young women of childbearing age. In the last two decades, a number of disease-modifying therapies have become available to treat relapsing forms of MS. None of these agents is approved for use in pregnancy. The timing of treatment versus conception, and risk of drug pregnancy exposures, are frequent discussion topics when caring for MS patients. This editorial will try to put into context available data, approaches, controversies and future needs.
authors.affiliation: Stony Brook University, Stony Brook MS Comprehensive Care Center, Department of Neurology , Stony Brook, NY , USA +1 631 444 8188 ; +1 631 444 1474 ; patricia.coyle@stonybrookmedicine.edu.
authors.forename: Patricia K
authors.initials: PK
authors.lastname: Coyle
mesh_terms: D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*
chemical_list: D007166:Immunosuppressive Agents
keywords: disease-modifying therapies; multiple sclerosis; pregnancy; pregnancy prescriptions